Determination of three isoforms of the receptor activator of nuclear factor-κB ligand and their differential expression in bone and thymus

Determination of three isoforms of the receptor activator of nuclear factor-κB ligand and their differential expression in bone and thymus
复制标题

DOI:
10.1210/en.142.4.1419
复制
发表时间:
2001-04-01
期刊:
影响因子:
4.8
通讯作者:
Hirokawa, K
Hirokawa, K
中科院分区:
医学2区
文献类型:
--
作者:
Ikeda, T;Kasai, M;Hirokawa, K

文献摘要

被引文献

相似文献

已知核因子(NF)-kappaB配体受体激活剂[RANKL;也称为肿瘤坏死因子相关激活诱导的细胞因子、骨保护素配体和破骨细胞分化因子]与NF-kappaB受体激活剂(RANK)结合,不仅是破骨细胞生成的关键因子,也是淋巴细胞发育的调节因子。在这项研究中,我们发现了另外两种RANKL亚型。RANKL,2具有比原始RANKL(RANKL 1)更短的细胞内结构域,RANKL,3缺乏跨膜结构域,被认为是可溶性形式。在骨髓基质细胞系ST 2和前成骨细胞系MC 3 T3-E1中,检测到所有三种RANKL亚型,但RANKL 2的表达优先被1 α,25-二羟维生素D-3和地塞米松抑制。在年轻成人胸腺中,CD 4(-)CD 8(-)双阴性细胞对所有三种亚型均呈阳性,CD 4(+)CD 8(+)双阳性细胞对RANKL 1和RANKL 3呈阳性,但对RANKL 2呈阴性,CD 4(+)CD 8(-)和CD 4(-)CD 8(+)单阳性细胞对所有三种亚型均呈阳性。用每种RANKL亚型转染的NIH 3 T3细胞的免疫荧光分析表明,三种RANKL亚型被翻译,RANKL 2蛋白主要停留在内质网和高尔基体网络中。这些结果表明存在三种RANXL-RANK通路。多个RANKL-RANK通路的存在表明破骨细胞生成或T细胞分化的RANKL-RANK系统比以前认为的更复杂。
The receptor activator of nuclear factor (NF)-kappaB ligand [RANKL; also known as tumor necrosis factor-related activation-induced cytokine, osteoprotegerin ligand, and osteoclast differentiation factor] is known to bind with the receptor activator of NF-kappaB (RANK) and act not only as a key factor for osteoclastogenesis but also as a regulator of lymphocyte development. In this study, we found two additional isoforms of RANKL. RANKL, 2 has a shorter intracellular domain than the original RANKL (RANKL 1), and RANKL, 3 lacks a transmembrane domain and was thought to act as a soluble form. In the bone marrow stromal cell line ST2 and preosteoblastic cell line MC3T3-E1, all three RANKL isoforms were detected, but the expression of RANKL 2 was preferentially suppressed by treatment with 1 alpha ,25-dihydroxyvitamin D-3 and dexamethasone. In young adult thymus, CD4(-)CD8(-) double-negative cells were positive for all three isoforms, CD4(+)CD8(+) double-positive cells were positive for RANKL 1 and RANKL 3 but negative for RANKL 2, and CD4(+)CD8(-) and CD4(-)CD8(+) single-positive cells were positive for all three isoforms. Immunofluorescence analyses of NIH3T3 cells transfected with each RANKL isoform indicated that the three RANKL, isoforms were translated, and RANKL, 2 protein predominantly stayed in the endoplasmic reticulum and Golgi networks. These results indicate that there are three kinds of RANXL-RANK pathways. The presence of multiple RANKL-RANK pathways suggests a more complicated RANKL-RANK system for osteoclastogenesis or T cell differentiation than previously thought.